The outlook of companies tied to blockbuster drugs like Viagra presents a nuanced investment picture. While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the patent expiration in key territories has introduced substantial uncertainty . Investors are now facing the consequences of generic com